Riskpilot← Back to searchSign inGet full accessAB Liby Läkeri
ABActiveOrg 5567825780Postgatan 1Tertiary education · NACE 8540Est. 20091 employees
Revenue 2025
SEK 493K
-9% vs 2024
EBITDA margin
50.3%
+1% vs 2024
Equity ratio
96.0%
Financial strength
Net profit 2025
SEK 168K
-38% vs 2024
| Revenue | SEK 493K | -9% |
| EBITDA | SEK 248K | +1% |
| Net profit | SEK 168K | -38% |
| Total assets | SEK 3M | -8% |
| Equity | SEK 2,8M | -1% |
| Employees | 1 | — |
Legal name
AB Liby Läkeri
Org number
5567825780
Legal form
Aktiebolag
NACE code
8540 · Tertiary education
Founded
15 maj 2009
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna
Company purpose
Bolaget skall bedriva sjukvård, medicinsk behandling och hälsovård, undervisning inom samma områden samt idka därmed förenlig verksamhet. Bolaget skall också producera och sälja olivolja.
Address
Postgatan 1
Email
ifriisliby@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 380 | 321 | 237 | 540 | 493 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −14 | −40 | 15 | 246 | 248 |
| Depreciation & amort. | −0 | −0 | −8 | −44 | −80 |
| EBIT | −14 | −40 | 7 | 202 | 168 |
| Net financials | 90 | 405 | 27 | 67 | 44 |
| Profit before tax | 76 | 451 | 122 | 345 | 212 |
| Tax | −19 | −27 | −27 | −73 | −44 |
| Net profit | 57 | 424 | 95 | 272 | 168 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 012 | 3 767 | 3 477 | 3 233 | 2 959 |
| Equity | 2 682 | 2 915 | 2 815 | 2 883 | 2 842 |
| Long-term debt | 9 | 637 | 552 | 170 | 17 |
| Short-term debt | 74 | 52 | 35 | 181 | 101 |
| Total debt | 83 | 689 | 587 | 351 | 118 |
EBITDA margin
50.3%
This company
15.8%
Market median
+218% vs market
20212025
Equity ratio
96.0%
This company
38.2%
Market median
+151% vs market
20212025
Return on equity
5.9%
This company
18.4%
Market median
-68% vs market
20212025
Net profit margin
34.1%
This company
8.1%
Market median
+321% vs market
20212025
Asset turnover
0.17×
This company
1.12×
Market median
-85% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
SA | Audit | 2021 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Board of Directors | 2021 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AB Liby Läkeri also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stellan Anders Jeanson | Audit | 0 companies |
| Axel Eric Viktor Friis-Liby | Deputy Board Member | 0 companies |
| Ingalill Kristina Friis-Liby | Board of Directors | 0 companies |
| Linn Martina Frida A Friis-Liby | Deputy Board Member | 0 companies |
| Jan-Eric Friis-Liby | Board of Directors | 0 companies |